Biotech Consulting
Argy, Wiltse and Robinson, P.C. (Argy) has deep expertise working with life science companies, including biotech companies, pursuing federal funding.
The global biotechnology industry has witnessed robust growth in 2008 revenue and investments, product pipeline strengthening, and launch of innovative products, technologies, services, and biotherapeutics. Argy’s life sciences consulting practice professionals have the expertise, resources, and regulatory knowledge to assist both public and private life sciences companies with financial issues allowing them to concentrate on the science.
In addition to the industry focused tax and accounting services, Argy also assists our life sciences clients with consulting services spanning the entire process around the capture of grant and contract funding, including:
- Proposal development
- Pricing strategy
- Cost accounting practices and procedures
- FAR compliance, USAID, HHS, NHI
- Assist with government audits and inquiries
- Contract management and administration
- Compliance programs and practices
- Training
- Effort reporting
- Cost sharing and cost transfers
- Special investigations
- Mergers and acquisitions assistance (buy- or sell-side)
- Prepare and negotiate equitable adjustment, delay, disruption, and termination claims
- Claims preparation, investigations and expert testimony
- Bid protests
- Analysis and recommendations for profit improvement and enhanced efficiencies including cost reduction programs
Our thorough knowledge of government regulatory issues separates us from our competitors. Argy hires and develops professionals with extensive hands-on government contracting experience, many of whom have worked in the industry. This allows us to provide proactive advice and function as key advisors to clients. Our approach and process for rendering services to our clients is fine-tuned and unmatched in terms of effectiveness and efficiency.
© 2010 Argy, Wiltse & Robinson, P.C., All Rights Reserved